We investigated whether Jun N-terminal kinase (JNK) and p38 mediate gonadotropin subunit transcriptional responses to pulsatile GnRH in normal rat pituitaries. A single pulse of GnRH or vehicle was given to female rats in vivo, pituitaries collected, and phosphorylated JNK and p38 measured. GnRH stimulated an increase in JNK phosphorylation within 5 min, which peaked 15 min after GnRH (3-fold). GnRH also increased p38 phosphorylation 2.3-fold 15 min after stimulus. Rat pituitary cells were given 60-min pulses of GnRH or media plus the JNK inhibitor SP600125 (SP, 20 M), p38 inhibitor SB203580 (20 M), or vehicle. In vehicle-treated groups, GnRH pulses increased LH␤ and FSH␤ primary transcript (PT) levels 3-fold. SP suppressed both basal and GnRH-induced increases in FSH␤ PT by half, but the magnitude of responses to GnRH was unchanged. In contrast, SP had no effect on basal LH␤ PT but suppressed the stimulatory response to GnRH. SB203580 had no effect on the actions of GnRH on either LH or FSH␤ PTs. L␤-T2 cells were transfected with dominant/ negative expression vectors for MAPK kinase (MKK)-4 and/or MKK-7 plus a rat LH␤ promoter-luciferase construct. GnRH stimulated a 50-fold increase in LH␤ promoter activity, and the combination of MKK-4 and -7 dominant/negatives suppressed the response by 80%. Thus, JNK (but not p38) regulates both LH␤ and FSH␤ transcription in a differential manner. For LH␤, JNK is essential in mediating responses to pulsatile GnRH. JNK also regulates FSH␤ transcription (i.e. maintaining basal expression) but does not play a role in responses to GnRH. (Endocrinology 149: 139 -145, 2008) 
G nRH REGULATES GONADOTROPIN subunit (␣,
LH␤, and FSH␤) transcription via a number of intracellular signaling pathways, including protein kinase A, protein kinase C (PKC), ERK, and calcium/calmodulin-dependent protein kinase type II (1) (2) (3) (4) . GnRH binding to the GnRH receptor (GnRH-R) activates several members of the GTPassociated protein family, including G q and G 11 , resulting in activation of phospholipase C ␤ , an increase in phosphoinositide turnover, and elevated diaclyglycerol levels, leading to an increase in the activity of PKC (2, 5) . GnRH-R binding also stimulates an increase in intracellular calcium that is derived from extracellular fluid (via L-type voltage sensitive calcium channels) and from inositol 1,4,5-trisphosphate-activated intracellular storage pools (2, 6) .
Recent findings reveal that calcium/calmodulin-dependent protein kinase type II plays an important role in GnRH transcriptional regulation of all three pituitary gonadotropin subunit (␣, LH␤, and FSH␤) genes (4, 7) . In contrast, published reports by our group and others found that ERK selectively mediates ␣-and FSH␤ transcriptional responses to GnRH but is not involved in LH␤ responses (8 -10) . To date, a LH␤-selective pathway for GnRH stimulation has yet to be characterized. Studies conducted in gonadotropederived cell lines (␣T3 and L␤T2 cells) reveal that GnRH activates two other members of the MAPK pathway, Jun N-terminal kinase (JNK)-1 through -3 and p38 (11) (12) (13) . However, the role played by these two pathways in mediating responses to pulsatile GnRH has yet to be elucidated.
In ␣T3 cells, GnRH activation of the p38 pathway is mediated via PKC, resulting in an increase in c-Jun and c-Fos expression (12) . However, there are few data to suggest a link between GnRH, p38 and regulation of gonadotropin subunit genes. Indeed, studies have shown that p38 does not mediate GnRH stimulation of ␣-subunit promoter activity in ␣T3 cells (12) or LH␤ protein expression in L␤T2 cells (13) . Whether p38 plays a role in GnRH actions on gonadotropin subunit transcription in normal rat gonadotropes remains to be determined.
In contrast to GnRH regulation of the ERK and p38 pathways, studies in gonadotrope-derived cell lines reveal that GnRH stimulates phosphorylation of JNK via activation of c-Src and cdc42, independent of PKC (11, 14) . GnRH-induced activation of JNK stimulates the phosphorylation and expression of c-Jun and expression of activating transcription factor-3 but not c-Fos (15) . Other findings suggest that JNK plays some role in GnRH stimulation of ␣, LH␤, and FSH␤ promoter activity (10, 11, 16) ; however, the role that JNK plays on the transcriptional regulation of endogenous rodent gonadotropin subunit genes remains unknown.
The purpose of the present study was to investigate whether JNK and p38 are activated in the rat pituitary by GnRH and whether these two members of the MAPK family mediate LH␤ and/or FSH␤ transcriptional responses to pulsatile GnRH. Based on our findings, we report that both JNK and p38 are activated by GnRH and that JNK (but not p38) regulates LH␤ and FSH␤ transcription in a differential manner.
Materials and Methods

Rat in vivo studies
All animal procedures were conducted in accordance with the National Research Council, Guide for the Care and Use of Laboratory Animals, and were approved by the University of Virginia Animal Care and Use Committee. In a preliminary study, we used a GnRH-deficient model (17) (castrate, testosterone-replaced, adult male rats), and gave a single iv injection of GnRH (300 ng) via a jugular cannula and euthanized 5, 15, or 60 min later (controls received a BSA-saline injection; n ϭ 4 -5 animals/group). Pituitaries were collected, homogenized in tissue lysis buffer [50 m HEPES, 100 mm NaCl, 2 mm EDTA, 0.1% Nonidet P-40, 1 m aprotinin, 1 mm Na orthovanadate (pH 7.5)], protein content measured, and phospho-JNK and phospho-p38 determined by ELISA.
Rat in vitro perifusion studies
For each experiment, pituitaries from 36 adult rats were pooled and dissociated in medium containing 0.35% collagenase, 0.1% hyaluronidase, and 0.01% DNase. After dissociation, the cell suspension was aliquoted into 12 culture wells (5-6 ϫ 10 6 cells/well) containing 22 mm plastic coverslips coated with Matrigel (Becton Dickinson, Bedford, MA). The cells were cultured for 48 h before beginning each experiment. The in vitro procedure and culture medium constituents have previously been described (7) . To allow LH␤ mRNA expression in response to pulsatile GnRH, testosterone [at a concentration present on proestrus, 500 pg/ml (18) ] was added during the last 24 h of plating and during perifusion. After plating, the coverslips were inserted into custom-made chambers and allowed to equilibrate for 1 h before initiating treatment. The perifusion flow rate was 200 l/min, and 100 l pulses were administered over a 10-sec duration via autosyringe pumps. Studies were conducted as four separate experiments (12 chambers per experiment), with all treatment groups represented in each experiment (three chambers/treatment per experiment). Data from each experiment were expressed as percent change vs. vehicle-pulsed controls.
GnRH pulse studies (ϮJNK or p38 blockers). Chambers were given pulses of GnRH (peak chamber concentration ϭ 200 pm, medium pulses to controls) every 60 min for 24 h. For JNK blocker studies, cells were perifused with medium containing the JNK-specific inhibitor SP600125 (SP; 20 m; Calbiochem, San Diego, CA) or vehicle [inactive SP isoform (20 m/0.25% dimethylsulfoxide; Calbiochem)]. For p38 inhibitor studies, cells were treated with medium containing the p38-specific blocker SB203580 (SB; 20 m; Calbiochem) or vehicle (0.1% dimethylsulfoxide). The SP and SB doses selected were based on previously published reports showing effective suppression of GnRH-induced activation of the JNK or p38 pathways within gonadotrope-derived cell lines (12, 15) . LH and FSH secretory responses were determined by collecting 10-min perifusate fractions over 60 min after 2 and 22 h (for 24-h studies) of treatment. Cells were recovered 10 min after the last pulse; total RNA extracted with guanidinium thiocyanate; and ␣, LH␤, and FSH␤ primary transcripts (PTs) determined by quantitative RT-PCR.
Transfection studies
Clonal L␤T2 gonadotropes were originally obtained from Dr. Pamela Mellon (University of California, San Diego, San Diego, CA) and maintained in DMEM supplemented with 10% fetal bovine serum and 1% antibiotic/antimycotic (Gibco, Grand Island, NY). For transfection, cells were plated using phenol red-free DMEM with 5% charcoal-stripped newborn calf serum and 2% l-glutamine at a concentration of 500,000 cells per 20-mm well. The following day, fresh phenol red-free DMEM 5% charcoal-stripped newborn calf serum was applied to cells before transfection with Lipofectamine 2000 according to the manufacturer's instructions (Invitrogen, Carlsbad, CA). A rat LH␤ luciferase reporter construct containing 617 bp upstream of the transcriptional start site has been described previously (9) and was used at a concentration of 0.5 g/well. Additionally, plasmid expression vectors for dominant-negative (DN) MAPK kinase (MKK)-4 (kindly provided by Dr. Michael Karin, University of California, San Diego, San Diego, CA) and/or MKK7 (kindly provided by Dr. Tse-Hua Tan, Baylor College of Medicine, Houston, TX) have been previously described (19) and were transfected with the rat LH␤ luciferase reporter (0.5 or 1.0 g/well). In all experiments, either the MKK4 parent vector (puc19) or MKK7 parent vector (pcDNA3.1) was added so that total plasmid DNA per well equaled 1.5 g/well. Approximately 16 h after transfection, cells were treated with either vehicle or 100 nm GnRH for 6 h. Cells were lysed using 1ϫ Promega lysis reagent (Madison, WI) and luciferase activity measured with a TD-20e luminometer (Turner Designs, Mountain View, CA). Protein concentrations of each sample were assayed using a protein assay reagent (Bio-Rad, Hercules, CA). Data are expressed as fold change, compared with vehicle or treatment controls. At least four independent experiments were performed, with triplicate samples in each experiment.
Phospho-JNK and phospho-38 assays
Activated (phosphorylated) JNK and p38 were determined in pituitary cell lysate protein (3 g per sample for phospho-JNK and 25 g for phospho-p38 assays) using phospho-JNK and phospho-p38 ELISA kits provided by Assay Designs, Inc. (Ann Arbor, MI). All samples were run within a single assay.
Quantitative RT-PCR
␣, LH␤, and FSH␤ PT concentrations were determined by quantitative RT-PCR assay, as previously described (20) . Primary transcript concentrations were expressed as femtomoles per 100 g pituitary RNA.
Intraassay coefficients of variation are 8.9 (␣), 6.7 (LH␤), and 5.0% (FSH␤); interassay coefficients of variation are 22.2 (␣), 19.2 (LH␤), and 14.1% (FSH␤). To reduce the effect of interassay variation, all samples from each experiment were run within a single PCR assay.
RIAs
LH and FSH secretory responses were measured in perifusate fractions by RIA, using reagents provided by the National Hormone and Pituitary Program (Torrance, CA). The assays were performed by the University of Virginia Center for Research in Reproduction, Ligand Assay and Analysis Core Facility. The RIA standards were NIDDK RP-3 (for LH) and RP-2 (for FSH). The assay sensitivities were 0.04 ng/tube for LH and 0.8 ng/tube for FSH. The coefficients of variation were 3.6 and 7.9% for the LH assay and 5.2 and 9.8% for FSH (intraassay and interassay, respectively). All samples from each experiment were assayed in a single RIA assay.
Statistical analysis
The data for phospho-JNK/p38, gonadotropin subunit PTs, and rat LH promoter activity were analyzed by one-way ANOVA, with differences between treatment groups determined by Duncan' multiple range test. LH and FSH secretory data were analyzed by two-way ANOVA, with time and treatment as the primary effects. Figure 1 shows the pituitary JNK and p38 activational response to a single pulse of GnRH in GnRH-deficient rats in vivo, as determined by measuring phosphorylated JNK (Fig. 1, upper panel) and phosphorylated p38 (Fig. 1, lower  panel) . GnRH stimulated a rapid rise in JNK phosphorylation (50% increase vs. vehicle treated controls 5 min after the pulse; P Ͻ 0.05). Maximal increases (3-fold) were seen 15 min after the pulse (P Ͻ 0.05 vs. control), which was maintained after the 60-min time point. p38 phosphorylation also tended to increase 5 min after GnRH treatment, but peak values were observed 15 min after the GnRH pulse (2.5-fold increase vs. control; P Ͻ 0.05) and were maintained through 60 min.
Results
To investigate whether the observed rise in JNK phosphorylation in response to GnRH plays a role in gonadotropin transcriptional regulation, GnRH pulses were given for 24 h in the absence or presence of the JNK-specific inhibitor SP. As shown in Fig 2, GnRH stimulated increases in LH␤ (3-fold) and FSH␤ (3.5-fold) PT [P Ͻ 0.05 vs. vehicle (Veh) controls]. A GnRH-induced increase in ␣ was not observed, but a small increase in ␣ PT was observed in chambers given GnRH pulsesϩSP vs. GnRHϩVeh (P Ͻ 0.05). SP suppressed both basal and GnRH-induced increases in FSH␤ PT by half (vs. Veh controls; P Ͻ 0.05), but the magnitude of responses to GnRH (3.5-fold increase) was unchanged. In contrast, SP had no effect on basal LH␤ PT (vs. Veh controls) but completely suppressed the stimulatory response to pulsatile GnRH.
To confirm that the inhibitory effect of SP on LH␤ transcriptional responses to GnRH is JNK pathway specific, follow-up studies were conducted using an experimental model in which JNK activation was suppressed by transfecting DN expression vectors for the two upstream activators of JNK (MKK-4 and MKK-7). Gonadotrope-derived L␤-T2 cells were transiently transfected with a rat LH␤ promoter/luciferase construct. Cells were cotransfected with MKK-4 DN or MKK-7 DN or in combination (controls were transfected with an equal amount of the appropriate empty plasmid vector). As shown in Fig. 3, 6 h of GnRH stimulated a 50-fold increase in LH␤ promoter activity (P Ͻ 0.05 vs. Veh control). Treatment of the cells with MKK-7 DN reduced the LH␤ promoter response to GnRH by 45% but did not achieve significance (vs. GnRHϩVeh). In contrast, the MKK-4 DN suppressed the stimulatory effect of GnRH on LH␤ promoter activity by 80% (P Ͻ 0.05 vs. GnRHϩVeh). Of interest, the LH␤ response to the combination of MKK-4 and MKK-7 DNs was not different from MKK-4 DN alone, suggesting that MKK-4 plays a primary role in GnRH-induced activation of JNK within the gonadotrope. Because the focus of this study was to investigate the role of JNK-mediating responses to pulsatile GnRH, cotransfection studies using MKK DNs and the rat FSH␤ promoter were not included.
The effect of SP on gonadotropin secretory responses to pulsatile GnRH after 2 and 22 h of treatment in vitro is shown in Fig. 4 . LH (2 and 22 h) and FSH (2 h) release in SP controls were not different from Veh controls and are not shown. GnRH stimulated a pulsatile LH and FSH release pattern that continued over 22 h. LH secretory responses to GnRH alone or in combination with SP were similar. FSH release responses to GnRH were also similar in Veh and SP-treated groups after 2 h. FSH secretion after 22 h (in both control and GnRH-treated groups) was elevated, compared with the initial phase of the study (2-h time point). However, SP inhibited FSH secretion after 22 h (both basal and responses to GnRH; P Ͻ 0.05 vs. Veh-treated groups).
To determine whether GnRH-induced increases in p38 activation play a role in gonadotropin transcriptional regulation, GnRH pulses were given in the absence or presence of the p38-specific inhibitor, SB. Similar to results seen in Fig.  2 , pulsatile GnRH stimulated 3-fold increases in both LH␤ and FSH␤ PT (P Ͻ 0.05 vs. Veh controls), but GnRH had no effect on ␣ PT (Fig. 5) . SB alone suppressed FSH␤ slightly (20% decrease vs. Veh controls; P Ͻ 0.05). However, SB had no effect on the stimulatory actions of GnRH on either LH␤ or FSH␤ PT expression.
As shown in Fig. 6 , GnRH pulses stimulated pulsatile secretion of both LH and FSH. For LH, the magnitude of responses to GnRH was similar after 2 and 22 h of treatment. For FSH, secretion in GnRH-treated groups increased after 22 h vs. the initial 2-h time point. p38 blocker (SB) treatment had no affect on either LH or FSH release, in contrast to results seen for JNK blockade on FSH (Fig. 4) .
Discussion
The present study showed that a single pulse of GnRH stimulated phosphorylation of both JNK and p38 in vivo in the rat pituitary, with a similar time course to previous reports for gonadotrope-derived cell lines (12, 13, 16) . Of particular significance, this study is the first to examine the role of JNK and p38 in the regulation of endogenous pathway plays an essential role in regulating both the rat LH␤ and FSH␤ genes. However, JNK showed differential actions on these two gonadotropin subunit genes. For LH␤, JNK is a critical player in mediating responses to pulsatile GnRH but does not influence basal transcriptional activity. In contrast, blocking the JNK pathway reduced basal FSH␤ PT, but the magnitude of responses to pulsatile GnRH remained unchanged.
At the secretory level, JNK blockade (SP) had no effect on either LH (after 2 or 22 h) or FSH (2 h) release. However, after 22 h, FSH secretion declined in both control and GnRH-treated groups, but responses to pulsatile GnRH were maintained. Interestingly, the pattern of FSH secretory responses to SP Ϯ GnRH near the end (22 h) of the experiment was similar to that seen for FSH␤ PT (i.e. a significant decrease in both basal and GnRH-induced stimulation, yet the magnitude of responses to GnRH was maintained). This suggests that ongoing basal transcription of FSH␤ relates to both basal FSH secretion and responses to GnRH. Prior work showed that pituitary storage capacity of both LH and FSH in the rat is quite high, and significant decreases in pituitary content is not seen unless the GnRH stimulus is maintained for an extended period of time [e.g. after GnRH-induced gonadotropin surges on proestrus or after several hours of rapid frequency (e.g. 7.5-min interval)/ high-amplitude pulses (21, 22) ]. It appears unlikely that the reduction in FSH release in the presence of the JNK blocker (SP) is due to a cytotoxic effect over time, because LH secretion [both basal (not shown) and responses to GnRH] were not reduced. Also, FSH secretion after 22 h in SP-treated cells was similar to responses seen in Veh and SP-treated groups after 2 h of treatment. Thus, the effect of SP on FSH after 22 h may represent a loss in the enhancement seen in other treatment groups (also seen in Fig. 6 ), rather than inhibition of secretion. These findings suggest that the JNK pathway may play a role in GnRH receptor activation/FSH secretion coupling over time.
The role of potential mediators of GnRH-R signaling has been investigated primarily using gonadotrope-derived cell lines (␣T3 and L␤T2 cells). Several studies have shown that alterations in intracellular calcium and PKC play a role in gonadotropin subunit transcription (23) (24) (25) . Other reports demonstrated that the ERK pathway mediates ␣, FSH␤, and GnRH-R transcriptional responses to GnRH (15, 16, 26) but not LH␤ (8 -10) . These later findings conflict with investigations showing that ERK does play a role in LH␤ transcriptional responses to GnRH in some cell lines (11, 27) . Although the explanation for the different results are unclear, cell type, experimental treatment paradigms, and gene products measured (i.e. transfected promoter constructs of various sizes vs. endogenous genes) are likely factors.
Prior studies have examined the potential role played by the JNK pathway in mediating GnRH signaling in ␣T3 and L␤T2 cells. Roberson and colleagues (15) showed that JNK cooperates with ERK to mediate human ␣-subunit transcriptional responses to GnRH. Other findings reveal that GnRH stimulates the ovine FSH␤ promoter via the JNK pathway (16). Yokoi et al. (10) found that JNK mediates GnRH-induced stimulation of the rat LH␤ promoter and that activation of c-Jun plays a role. Results also indicated that various components of the JNK activational cascade (including c-Src, CDC42, Rac, and SEK) are involved in the GnRH signal transduction pathway (11, 16) . In the present study using primary pituitary cells, the JNK-specific blocker (SP) completely suppressed the LH␤ transcriptional response to pulsatile GnRH. This response was confirmed and extended by showing that DNs of the two primary upstream activators of JNK 1-3 (MKK-4 and MKK-7) suppress rat LH␤ promoter stimulation by GnRH in L␤-T2 cells. Of interest, these results suggest that MKK-4 is a major mediator of GnRH actions on the JNK pathway within the gonadotrope because the decrease in GnRH-induced stimulation of LH␤ promoter activity in the presence of MKK-4 DN alone was similar to the combination of MKK-4 and MKK-7 DNs. In contrast to results seen for SP, DN treatment did not completely block the LH␤ stimulatory response to GnRH. This difference may be due to the experimental models or end product measured. Similar partial LH␤ promoter responses were seen by Harris et al. (11) , using various transiently transfected JNK pathway DNs (i.e. c-Src, CDC42, Rac, and SEK).
The downstream mediator(s) of GnRH/JNK actions on rat LH␤ transcription remain to be elucidated. GnRH-induced activation of JNK stimulates an increase in total and activated c-Jun in gonadotrope-derived cell lines (15) , and transfecting a c-Jun DN suppressed GnRH stimulation of rat LH␤ promoter activity (10) . That same group described a region of the rat promoter (Ϫ95 to Ϫ86 bp) that contains 75% homology to the consensus activator protein-1 site and postulated that c-Jun might mediate JNK signaling via actions at this site. Another potential mediator of JNK actions is early growth response protein (Egr)-1 because JNK activation stimulates Egr-1 expression in the prostate (28) . Binding sites for Egr-1 and other critical transcription factors (i.e. steroidogenic fac- tor-1, pituitary homeobox-1) (28, 29) are present in the proximal GnRH response element of the rat LH␤ promoter. Rapid frequency GnRH pulses, the optimal signal pattern for LH␤ transcription, was more effective than slower frequency pulses in stimulating Egr-1 mRNA, protein expression, and protein migration to the nucleus (27, 30) . Furthermore, we reported that pulsatile GnRH stimulates an increase in Egr-1 PT and mRNA, an effect that is completely suppressed by JNK blockade using SP (31) .
Our data also suggest that JNK plays a stimulatory role in the regulation of the rat FSH␤ gene. However, as apposed to LH␤, the effect appears to be primarily through actions on basal transcription. In contrast, studies conducted using the ovine FSH␤ promoter showed that JNK partially mediates responses to GnRH (16) . The observation that activator protein-1 plays a role in the ovine FSH␤ promoter response to GnRH (32) as well as data showing that JNK stimulates c-Jun expression and phosphorylation in gonadotrope-derived cell lines (15) , supports a role for JNK in the ovine system that differs from the rat.
Data in Figs. 2 and 5 show that ␣ PT was not increased after 24 h of 60-min pulses of GnRH. Because 50% of basal ␣ PT levels in primary pituitaries are contained in thyrotrope cells, responses to GnRH are less marked. Also, in previous in vitro time course studies, we showed that maximal increases in LH␤ and FSH␤ PT are seen after 24 h of GnRH pulses. However, that same study showed that ␣ PT is maximally stimulated by 14 h of pulsatile GnRH treatment, with responses declining over longer durations (7) . Because LH␤ and FSH␤ were the primary focus of this investigation, a 24-h experimental duration was chosen. Previous studies reported that the JNK pathway plays a role in human ␣ transcription via activation of the epidermal growth factor receptor and partially mediates the stimulatory response to GnRH via activating transcription factor-3 (15, 33) . However, because we did not observe a GnRH-induced increase in ␣ PT, we cannot say whether JNK plays a role in stimulating ␣-subunit transcriptional responses to GnRH in the rat.
Various investigators have shown that GnRH stimulates p38 activation within gonadotrope-derived cell lines (11) (12) (13) , and the present study is the first to show similar responses within primary pituitary cells. Also, blocking p38 activation with SB did not suppress GnRH-induced responses for LH␤ and FSH␤ transcription or LH/FSH secretion. Our findings for LH␤ are similar to previously published reports, which showed that p38 does not regulate LH␤ protein expression (13) . In contrast, p38 may play a role in mediating GnRH stimulatory effects on the ovine FSH␤ gene (16, 34) . Studies by Miller and colleagues (34) showed that activation of the TGF␤ receptor stimulates ovine FSH␤ promoter activity via two pathways, activin and p38. Based on the present findings, p38 may also have a partial action on the rat FSH␤ gene (Fig. 5 ) because blocking the p38 pathway (SB) produced a small suppression of basal FSH␤ PT levels. However, the present results suggest that, unlike the ovine gene, GnRH does not stimulate rat FSH␤ transcription through the p38 pathway.
In summary, the present results show that JNK, but not p38, plays an important role in mediating gonadotropin subunit transcription. More specifically, JNK regulates both LH␤ and FSH␤ transcription in a differential manner. For LH␤, JNK plays an essential role in mediating the transcriptional responses to pulsatile GnRH. The JNK pathway also regulates FSH, at both the transcriptional (i.e. maintaining basal FSH␤ gene expression) and secretory levels. These findings present a potential intracellular mechanism for divergent regulation of gonadotropin subunit gene expression and LH/FSH secretion.
